OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease
Simon Lebek, Francesco Chemello, Xurde M. Caravia, et al.
Science (2023) Vol. 379, Iss. 6628, pp. 179-185
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Regulated cell death in myocardial ischemia–reperfusion injury
Q. Xiang, Xin Yi, Xue‐Hai Zhu, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 3, pp. 219-234
Closed Access | Times Cited: 132

Drug delivery systems for CRISPR-based genome editors
Victoria J. Madigan, Feng Zhang, James E. Dahlman
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 875-894
Closed Access | Times Cited: 74

Precise genome-editing in human diseases: mechanisms, strategies and applications
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18

Role of CAMK2D in neurodevelopment and associated conditions
Pomme M.F. Rigter, Charlotte de Konink, Matthew J. Dunn, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 2, pp. 364-382
Open Access | Times Cited: 15

MicroRNA-122–Mediated Liver Detargeting Enhances the Tissue Specificity of Cardiac Genome Editing
Luzi Yang, Zhanzhao Liu, Gonglie Chen, et al.
Circulation (2024) Vol. 149, Iss. 22, pp. 1778-1781
Open Access | Times Cited: 9

CaMKII at the crossroads: calcium dysregulation, and post‐translational modifications driving cell death
Alicia Mattiazzi, C Giusti, Carlos A. Valverde
The Journal of Physiology (2025)
Closed Access | Times Cited: 1

CRISPR innovations in tissue engineering and gene editing
ZahraSadat Razavi, M. Soltani, Mohammad Souri, et al.
Life Sciences (2024), pp. 123120-123120
Open Access | Times Cited: 8

One Endothelium-Targeted Combined Nucleic Acid Delivery System for Myocardial Infarction Therapy
Yihui Shao, Xu Chen, Shuolin Zhu, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8107-8124
Closed Access | Times Cited: 7

Genome Editing and Cardiac Arrhythmias
Oliver M. Moore, Kevin S. Ho, Juwan Copeland, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1363-1363
Open Access | Times Cited: 15

Base editors: development and applications in biomedicine
Yanhui Liang, Fangbing Chen, Kepin Wang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 359-387
Closed Access | Times Cited: 13

CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse model
Simon Lebek, Xurde M. Caravia, Leon G. Straub, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 1
Open Access | Times Cited: 13

From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine
Weihui Xu, Shiyao Zhang, Huan Qin, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice
Simon Lebek, Xurde M. Caravia, Francesco Chemello, et al.
Circulation (2023) Vol. 148, Iss. 19, pp. 1490-1504
Open Access | Times Cited: 11

Calcium signaling from sarcoplasmic reticulum and mitochondria contact sites in acute myocardial infarction
Esther Densu Agyapong, Gaia Pedriali, Daniela Ramaccini, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions
Mengmeng Wang, De-Gang Mo, Ning Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35219-e35219
Open Access | Times Cited: 4

AAV-mediated gene therapies by miniature gene editing tools
Xiangfeng Kong, Tong Li, Hui Yang
Science China Life Sciences (2024)
Closed Access | Times Cited: 4

Editorial: Insights in cardiovascular and smooth muscle pharmacology: 2023
Sönke Schildt, Daniel Reichart, Simon Lebek
Frontiers in Pharmacology (2025) Vol. 15
Open Access

LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy
Ze Wang, Jiahao Wu, Zhongwei Lv, et al.
Journal of Advanced Research (2025)
Open Access

miR‐199a‐3p mitigates simulated microgravity‐induced cardiac remodeling by targeting MEF2C
Junjie Pan, Jianwei Li, Jianhua Li, et al.
The FASEB Journal (2025) Vol. 39, Iss. 2
Closed Access

Cardioprotective Effects of hUCMSCs-Exosi-EGR1 MN Patch in MI/RI by Modulating Oxidative Stress and Mitophagy
Chenyang Huang, Xun Zhang, Shi-Xiong Wu, et al.
Materials Today Bio (2025) Vol. 31, pp. 101500-101500
Open Access

Phospholipase C epsilon 1 as a therapeutic target in cardiovascular diseases
Jie Wang, Ting Gao, Dongmei Zhang, et al.
Journal of Advanced Research (2025)
Open Access

Gene therapy for genetic diseases: challenges and future directions
Beibei QIE, Jingsheng Tuo, Feilong Chen, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access

Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease
Meiling Cao, Ruirui Han, Shungen Chen, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4001-4018
Open Access

Page 1 - Next Page

Scroll to top